392
Participants
Start Date
September 30, 2006
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
Group 1
Individuals with Prader-Willi syndrome. Monitoring every 6 months.
Group 2
Individuals with Early-onset Morbid Obesity.
Vanderbilt University Medical Center, Nashville
Kansas University Medical Center, Kansas City
University of California at Irvine, Orange
University of Florida, Gainesville
Office of Rare Diseases (ORD)
NIH
Rare Diseases Clinical Research Network
NETWORK
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
University of Florida
OTHER